An official of China’s Centre for Disease Control and Prevention (CDC) recently reported that china’s indigenous coronavirus vaccines may be ready for use by the general population latest by the end of the present year.
China currently has four Covid-19 vaccines that are in the final stage of clinical trials. Out of them, three have been made available for emergency use to essential workers under a programme launched in the month of July.
CDC chief biosafety expert, Guizhen Wu on Monday said, “Phase 3 clinical trials were proceeding smoothly and the vaccines could be ready for the general public in November or December.”
However, she does not specify the names of the vaccine that she mentioned in her statement.
The three vaccines are being developed under China’s emergency use programme by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and US-listed Sinovac Biotech. In July, Sinopharm stated that its vaccine is likely to be ready for public use by the end month of the present year following the completion of Phase 3 trials.
A fourth Covid-19 vaccine that is being developed by CanSino Biologics got required approval for use by the Chinese military in the month of June.